Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03098849
Other study ID # RBT_10
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 25, 2017
Est. completion date October 26, 2017

Study information

Verified date May 2018
Source ARCIM Institute Academic Research in Complementary and Integrative Medicine
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to investigate the effects of a Buteyko-based breathing technique on physiological and psychological parameters in adults with asthma


Description:

The investigators explore the effects of a Buteyko-based breathing technique training using a treatment group vs. control group design and a repeated measures design with follow-up measurements 3 and 6 months after the intervention. The sample size calculation was made for an effect of d = .20 with repeated measures, a power of 1- β = .80 and α = .05. Additionally the investigators plan to take measurements (only once) from healthy volunteers matching them (age and gender) with the asthma patients.


Recruitment information / eligibility

Status Completed
Enrollment 63
Est. completion date October 26, 2017
Est. primary completion date October 26, 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria:

- Written informed consent, regular intake of prescribed asthma medication according to the AWMF scheme level 1, native speaker of german

Exclusion Criteria:

- Participation in another study, comorbidities (heart diseases, cancer still under treatment, psychiatric diseases)

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Buteyko Breathing Technique
Patients are trained in various exercises aiming at breath reduction and breath control as introduced by Dr. K. Buteyko

Locations

Country Name City State
Germany ARCIM Institute Filderstadt Baden Württemberg

Sponsors (2)

Lead Sponsor Collaborator
ARCIM Institute Academic Research in Complementary and Integrative Medicine University Hospital Tuebingen

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in Endtidal CO2 Capnometry Between baseline and 3 month follow up
Primary Change in Nijmegen-Score Questionnare assessing hyperventilation Between baseline and 3 month follow up
Primary Change in Buteyko CP Breath hold test Between baseline and 3 month follow up
Secondary Spirometry: FEV1 FEV1 Between baseline and 3 month follow up
Secondary Spirometry: FEV1 FEV1 Between baseline and 6 month follow up
Secondary Spirometry: FEV1/VCin FEV1/VCin Between baseline and 3 month follow up
Secondary Spirometry: FEV1/VCin FEV1/VCin Between baseline and 6 month follow up
Secondary Spirometry: PEF PEF Between baseline and 3 month follow up
Secondary Spirometry: PEF PEF Between baseline and 6 month follow up
Secondary Heart Rate Variability (SDNN) SDNN Between baseline and 3 month follow up
Secondary Heart Rate Variability (SDNN) SDNN Between baseline and 6 month follow up
Secondary Heart Rate Variability (RMSSD) RMSSD Between baseline and 3 month follow up
Secondary Heart Rate Variability (RMSSD) RMSSD Between baseline and 6 month follow up
Secondary Heart Rate Variability (LF/HF) LF/HF Between baseline and 3 month follow up
Secondary Heart Rate Variability (LF/HF) LF/HF Between baseline and 6 month follow up
Secondary Vascular stiffness Pulse Wave Velocity Between baseline and 3 month follow up
Secondary Vascular stiffness Pulse Wave Velocity Between baseline and 6 month follow up
Secondary Blood Pressure Systolic and Diastolic Between baseline and 3 month follow up
Secondary Blood Pressure Systolic and Diastolic Between baseline and 6 month follow up
Secondary Haemodynamics Stroke volume Stroke volume Between baseline and 3 month follow up
Secondary Haemodynamics Stroke volume Stroke volume Between baseline and 6 month follow up
Secondary Haemodynamics Cardiac output Cardiac output Between baseline and 3 month follow up
Secondary Haemodynamics Cardiac output Cardiac output Between baseline and 6 month follow up
Secondary Haemodynamics Total Vascular Resistance Total Vascular Resistance Between baseline and 3 month follow up
Secondary Haemodynamics Total Vascular Resistance Total Vascular Resistance Between baseline and 6 month follow up
Secondary Haemodynamics Cardiac index Cardiac index Between baseline and 3 month follow up
Secondary Haemodynamics Cardiac index Cardiac index Between baseline and 6 month follow up
Secondary Haemodynamics Perfusion Perfusion index Between baseline and 3 month follow up
Secondary Haemodynamics Perfusion Perfusion index Between baseline and 6 month follow up
Secondary Haemodynamics Plethvariability Plethvariability index (PVI) Between baseline and 3 month follow up
Secondary Haemodynamics Plethvariability Plethvariability index (PVI) Between baseline and 6 month follow up
Secondary Oxygen Saturation SpO2 Between baseline and 3 month follow up
Secondary Oxygen Saturation SpO2 Between baseline and 6 month follow up
Secondary ACQ Asthma Control Questionnaire, E. Juniper Between baseline and 3 month follow up
Secondary ACQ Asthma Control Questionnaire, E. Juniper Between baseline and 6 month follow up
Secondary AQLQ Asthma Quality of Life Questionnaire, E. Juniper Between baseline and 3 month follow up
Secondary AQLQ Asthma Quality of Life Questionnaire, E. Juniper Between baseline and 6 month follow up
Secondary ARCIM Questionnaire Questionnaire focusing on respiratory complaints like mucus, snoring, blocked nose. Between baseline and 3 month follow up
Secondary ARCIM Questionnaire Questionnaire focusing on respiratory complaints like mucus, snoring, blocked nose. Between baseline and 6 month follow up
Secondary STAI Questionnaire State and Trait Anxiety Inventory Between baseline and 3 month follow up
Secondary STAI Questionnaire State and Trait Anxiety Inventory Between baseline and 6 month follow up
Secondary ASF Questionnaire "Aachener Selbstwirksamkeitsfragebogen" Between baseline and 3 month follow up
Secondary ASF Questionnaire "Aachener Selbstwirksamkeitsfragebogen" Between baseline and 6 month follow up
Secondary Asthma medication Kind and dosage of asthma specific medication like steroids or betamimetics Between baseline and 3 month follow up
Secondary Asthma medication Kind and dosage of asthma specific medication like steroids or betamimetics Between baseline and 6 month follow up
See also
  Status Clinical Trial Phase
Terminated NCT04410523 - Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma Phase 2
Completed NCT04624425 - Additional Effects of Segmental Breathing In Asthma N/A
Active, not recruiting NCT03927820 - A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR) N/A
Completed NCT04617015 - Defining and Treating Depression-related Asthma Early Phase 1
Recruiting NCT03694158 - Investigating Dupilumab's Effect in Asthma by Genotype Phase 4
Terminated NCT04946318 - Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma Phase 2
Completed NCT04450108 - Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients N/A
Completed NCT03086460 - A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH) Phase 2
Completed NCT01160224 - Oral GW766944 (Oral CCR3 Antagonist) Phase 2
Completed NCT03186209 - Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE) Phase 3
Completed NCT02502734 - Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma Phase 3
Completed NCT01715844 - L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics Phase 1
Terminated NCT04993443 - First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036 Phase 1
Completed NCT02787863 - Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology Phase 4
Recruiting NCT06033833 - Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study Phase 2
Completed NCT03257995 - Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma. Phase 2
Completed NCT02212483 - Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients N/A
Recruiting NCT04872309 - MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
Withdrawn NCT01468805 - Childhood Asthma Reduction Study N/A
Recruiting NCT05145894 - Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device